Abattis Bioceuticals (Abattis Bioceuticals) Market Cap : $0.00 Mil (As of Jun. 07, 2024)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Abattis Bioceuticals's share price for the quarter that ended in Sep. 2019 was $0.02. Abattis Bioceuticals's Shares Outstanding (EOP) for the quarter that ended in Sep. 2019 was 477.80 Mil. Therefore, Abattis Bioceuticals's market cap for the quarter that ended in Sep. 2019 was $9.56 Mil.

Abattis Bioceuticals's quarterly market cap stayed the same from Mar. 2019 ($14.33 Mil) to Jun. 2019 ($14.33 Mil) but then declined from Jun. 2019 ($14.33 Mil) to Sep. 2019 ($9.56 Mil).

Abattis Bioceuticals's annual market cap increased from Sep. 2017 ($26.53 Mil) to Sep. 2018 ($59.55 Mil) but then declined from Sep. 2018 ($59.55 Mil) to Sep. 2019 ($9.56 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Abattis Bioceuticals's Enterprise Value for Today is $0.00 Mil.

Abattis Bioceuticals Market Cap Historical Data

The historical data trend for Abattis Bioceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Market Cap Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Market Cap

Get a 7-Day Free Trial

3.07

5.50

26.53

59.55

9.56

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Market Cap	Get a 7-Day Free Trial															59.55	23.85	14.33	14.33	9.56

Competitive Comparison of Abattis Bioceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abattis Bioceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's Market Cap falls into.

Abattis Bioceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Abattis Bioceuticals's Market Cap for the fiscal year that ended in Sep. 2019 is calculated as

Market Cap (A: Sep. 2019 )	=	Share Price (A: Sep. 2019 )	*	Shares Outstanding (EOP) (A: Sep. 2019 )
	=	$0.02	*	477.804
	=	$9.56

Abattis Bioceuticals's Market Cap for the quarter that ended in Sep. 2019 is calculated as

Market Cap (Q: Sep. 2019 )	=	Share Price (Q: Sep. 2019 )	*	Shares Outstanding (EOP) (Q: Sep. 2019 )
	=	$0.02	*	477.804
	=	$9.56

Abattis Bioceuticals (OTCPK:ATTBF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Abattis Bioceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.